Eric N. Olson
Scientific Founder & Member of Scientific Advisory BoardDr. Eric N. Olson, Ph.D., is Founder and Chief Science Advisor of Exonics Therapeutics, Inc. He was Science Partner of The Column Group, LLC until 2025. Dr. Olson was employed at The Column Group, LLC until 2025. He is the Co-Founder of Velia Inc. He is the Member of Scientific Advisory Board at Prime Medicine, Inc, Tenaya Therapeutics. He co-founded Lonestar Heart, Inc. in 2010 and serves as its Chief Scientific Advisor. Dr. Olson serves as a Member of Scientific Advisory Board at ReCode Therapeutics, Inc., since November 2022. Dr. Olson is a Scientific Founder and Member of Scientific Advisory Board of Tenaya Therapeutics, Inc. He serves as Chairman of Scientific Advisory Board at Cardurion Pharmaceuticals, LLC. Dr. Olson co-founded Viridian Therapeutics, Inc. (Formerly known as Miragen Therapeutics, Inc.) in 2006 and served as its Chief Scientific Advisor. Dr. Olson serves as a Professor and Chairman of Department of Molecular Biology of University of Texas Southwestern. He joined the Department of Biochemistry and Molecular Biology at The M.D. Anderson Cancer Center in 1984 and became Professor and Chairman. He also serves as an Associate Director of the D.W. Reynolds Center of Cardiovascular Medicine at the University of Texas Southwestern Medical Center. He serves as a Director at Lonestar Heart, Inc. He serves as a Director of the Hamon Center for Basic Research in Cancer. Dr. Olson has focused on discovering novel transcription factors that control development of these muscle cell types and remodeling in response to cardiovascular and neuromuscular diseases. Dr. Olson has been a Member of Scientific Advisory Board at Stowers Institute For Medical Research Inc. since 2000. He serves as a Member of Scientific Review Board for Howard Hughes Medical Institute. Dr. Eric has been Chairman of Scientific Advisory Board of Viridian Therapeutics, Inc. (Formerly known as Miragen Therapeutics, Inc.) and serves as its Member of Scientific Advisory Board since January 2010. He served as a Member of Scientific Advisory Board - Cardiac Regeneration of Hydra Biosciences, Inc. He holds the Robert A. Welch Distinguished Chair and the Annie and Willie Nelson Professorship of Stem Cell Research. Dr. Olson and his trainees discovered many of the key transcription factors and mechanisms responsible for heart and muscle development and disease. Dr. Olson is a Member of the U.S. National Academy of Sciences, the National Academy of Medicine and the American Academy of Arts and Sciences. Dr. Eric has co-founded multiple biotechnology companies, including Myogen Therapeutics and Miragen Therapeutics to design innovative therapies for heart and muscle disease. Dr. Olson attended Wake Forest University receiving a B.A. in Chemistry and Biology, a Ph.D. in Biochemistry and an honorary doctorate. He completed postdoctoral training at Washington University School of Medicine.
Positions
- Company NameTenaya Therapeutics, Inc.Stock CodeTNYAPositionScientific Founder & Member of Scientific Advisory BoardColleagues
- FAFaraz AliPresident, CEO & Director
- DSDeepak SrivastavaScientific Founder, Chairman of Scientific Advisory Board & Director
- WGWhittemore G. TingleyChief Medical Officer
- ENEric N. OlsonScientific Founder & Member of Scientific Advisory Board
- BRBruce R. ConklinScientific Founder
- JTJeffrey T. WalshIndependent Director
- JHJune H. LeeIndependent Director
- Company NameViridian Therapeutics, Inc.Stock CodeVRDNPositionCo-Founder & Chairman of Scientific Advisory BoardColleagues
- SFStephen F. MahoneyCEO, President & Director
- TKTomas KiselakIndependent Chairperson of Board
- SHSeth HarmonChief Financial Officer
- TWThomas W. BeethamChief Operating Officer
- JTJennifer TousignantChief Legal Officer & Corporate Secretary
- RTRadhika TripuraneniChief Medical Officer
- MRMichael R. BristowCo-Founder & Member of the Scientific Advisory Board
- MHMarvin H. CaruthersCo-Founder & Scientific Advisory Board Member
